EPI 12323
Alternative Names: EPI-12323; NaturasoneLatest Information Update: 29 Jun 2016
At a glance
- Originator EpiGenesis Pharmaceuticals
- Class Antiasthmatics; Small molecules; Steroids
- Mechanism of Action Adenosine deaminase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Allergic rhinitis; Asthma; Chronic obstructive pulmonary disease
Most Recent Events
- 09 Jul 2013 Discontinued - Phase-I for Allergic rhinitis in USA (Inhalation)
- 09 Jul 2013 Discontinued - Phase-I for Asthma in USA (Inhalation)
- 09 Jul 2013 Discontinued - Phase-I for Chronic obstructive pulmonary disease in USA (Inhalation)